What Is the Recurrence Risk for Triploidy Syndrome?
At a Glance
Triploidy usually results from a random chromosome error and is unlikely to recur. After isolated non-molar triploidy, recurrence risk is generally below 1%; after a partial molar pregnancy, the risk of another molar pregnancy is about 1% to 2%, with hCG monitoring recommended.
In this answer
4 sections
Losing a pregnancy to triploidy syndrome is a heartbreaking experience, and it is completely normal to worry about the health of your future pregnancies. The most important thing to know is that your chances of having another pregnancy affected by triploidy are extremely low [1].
Because triploidy is almost always a random, sporadic event, the exact recurrence risk depends on the specific type of triploidy you experienced:
- Isolated Non-Molar Triploidy: If the pregnancy was not a molar pregnancy, the risk of recurrence is generally considered to be near the background population risk (less than 1%) [1][2].
- Partial Hydatidiform Mole: If the triploidy resulted in a partial molar pregnancy, the recurrence risk for a future molar pregnancy is approximately 1% to 2% [3].
While no doctor can guarantee a healthy pregnancy, this means there is an overwhelmingly high chance (98% to over 99%) that your next pregnancy will not have this specific condition.
A Sporadic Biological Error
To understand why it is unlikely to happen again, it helps to know how triploidy occurs. A typical embryo has 46 chromosomes (23 from the egg and 23 from the sperm). Triploidy happens when an embryo receives an entire extra set of 23 chromosomes, resulting in 69 chromosomes [4].
This biological error usually happens in one of two ways:
- Dispermy (Extra Paternal Set): Two sperm fertilize a single egg [4]. This results in an extra set of paternal chromosomes (called diandric triploidy) and is commonly associated with a partial hydatidiform mole, a condition where the placenta grows abnormally [5][6].
- Cell Division Errors (Extra Maternal or Paternal Set): An egg or sperm fails to divide properly during development (a process called meiosis), retaining a double set of chromosomes instead of a single set [4]. When the extra set comes from the mother (called digynic triploidy), it typically results in a non-molar triploid pregnancy [6].
Because these are random biological errors, they are not caused by anything you did, and they are not typically passed down through families [1].
Follow-up Care and hCG Monitoring
If your pathology report confirms a partial molar pregnancy (diandric triploidy), your doctor will recommend a series of blood tests to monitor your hCG levels (the pregnancy hormone) [6][7]. The goal is to ensure the hCG levels drop to a negative or normal non-pregnant range.
This surveillance is crucial because, in rare cases, abnormal molar cells can remain in the uterus and continue to grow, a condition known as gestational trophoblastic disease (GTD) [7]. Your care team will advise you to use reliable contraception and avoid getting pregnant while undergoing this monitoring. A new pregnancy would cause your hCG levels to rise, making it impossible to tell if the molar tissue has completely resolved [7].
What About Rare Genetic Mutations?
You may have read online about specific maternal genetic mutations—such as NLRP7 or KHDC3L—and wondered if you should be tested. These genes provide instructions for proteins that help an egg develop properly. When these genes have pathogenic variants (mutations), they can cause a predisposition to recurrent hydatidiform moles [8][9].
However, these mutations are exceedingly rare and are almost never the cause of a single, isolated triploid pregnancy [8]. Doctors typically only consider testing for these genetic variants if a woman has experienced multiple molar pregnancies, particularly rare biparental moles, or has a strong family history of recurrent molar pregnancies [10]. Other extremely rare gene variations, such as CCNB3, have been linked to recurrent cases of non-molar triploidy, but testing for this is generally limited to research or highly specialized genetics settings after multiple losses [11].
Planning for Your Next Pregnancy
When you are medically cleared and ready to try again, your next steps will depend on your prior diagnosis. While there is no medical intervention that prevents triploidy, you can work with your care team to create a monitoring plan that may be helpful for your peace of mind.
- Review the Pathology: Ensure your doctor has reviewed the final chromosome and pathology reports from your loss to clarify if it was a partial mole or non-molar triploidy.
- Early Monitoring: Once you conceive, contact your obstetric team early. Many doctors will offer an early ultrasound to check the pregnancy’s development and the placenta.
- Genetic Counseling: If you have experienced more than one molar pregnancy, recurrent pregnancy loss, or severe anxiety, a referral to a genetic counselor may be helpful. A counselor can personalize your risks based on your specific pathology reports and discuss available screening or diagnostic testing options.
Common questions in this guide
What is the chance that triploidy will happen in my next pregnancy?
Does a partial molar pregnancy change the recurrence risk?
Why does triploidy usually not recur?
What follow-up is needed after a partial molar pregnancy?
Should I have genetic testing after one triploid pregnancy?
How can I prepare for another pregnancy after triploidy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Did my final pathology and chromosome report confirm whether my pregnancy was a partial hydatidiform mole (diandric triploidy) or non-molar triploidy?
- 2.Do I need serial hCG blood tests to monitor for gestational trophoblastic disease, and how long must I wait before attempting to conceive again?
- 3.Once I am pregnant again, can we schedule an early ultrasound to check the development of the pregnancy and placenta?
- 4.Based on my specific test results and history, would speaking with a genetic counselor be helpful before I try to conceive again?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Recurrent fetal triploidy: is there a genetic cause?
Fontoura Oliveira A, Torrão MM, Nogueira R, Ferreira M
BMJ case reports 2021; (14(3)) doi:10.1136/bcr-2020-239843.
PMID: 33653854 - 2
Triploid pregnancy-Clinical implications.
Massalska D, Bijok J, Kucińska-Chahwan A, et al.
Clinical genetics 2021; (100(4)):368-375 doi:10.1111/cge.14003.
PMID: 34031868 - 3
Generation and characterization of human iPSC lines (FAHZJUi001-A and FAHZJUi002-A) from two familial recurrent hydatidiform mole patients carrying homozygous mutation in the NLRP7 gene.
Cai L, Wan J, Zhao Y, et al.
Human cell 2026; (39(1)):34 doi:10.1007/s13577-025-01346-0.
PMID: 41535518 - 4
Gestational Trophoblastic Disease: Complete versus Partial Hydatidiform Moles.
Gonzalez J, Popp M, Ocejo S, et al.
Diseases (Basel, Switzerland) 2024; (12(7)) doi:10.3390/diseases12070159.
PMID: 39057130 - 5
Prevalence of Partial Hydatidiform Mole in Products of Conception From Gestations With Fetal Triploidy Merits Reflex Genotype Testing Independent of the Morphologic Appearance of the Chorionic Villi.
Han LM, Grenert JP, Wiita AP, et al.
The American journal of surgical pathology 2020; (44(6)):849-858 doi:10.1097/PAS.0000000000001466.
PMID: 32205485 - 6
Diandric triploid partial mole versus digynic nonmolar triploidy: is morphological assessment sufficient for the diagnostic distinction?
Nagy A, Niu N, Sun T, et al.
Histopathology 2024; (85(6)):879-888 doi:10.1111/his.15247.
PMID: 39031756 - 7
The Contribution of QF-PCR and Pathology Studies in the Diagnosis of Diandric Triploidy/Partial Mole.
Benítez L, Pauta M, Badenas C, et al.
Diagnostics (Basel, Switzerland) 2021; (11(10)) doi:10.3390/diagnostics11101811.
PMID: 34679509 - 8
The genetics of recurrent hydatidiform moles: new insights and lessons from a comprehensive analysis of 113 patients.
Nguyen NMP, Khawajkie Y, Mechtouf N, et al.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2018; (31(7)):1116-1130 doi:10.1038/s41379-018-0031-9.
PMID: 29463882 - 9
A Maternal Loss-of-Function Variant in KHDC3L Gene Causes a Range of Adverse Pregnancy Outcomes: A Case Report.
Anvar Z, Jafarpour F, Jahromi BN, et al.
Molecular genetics & genomic medicine 2025; (13(1)):e70051 doi:10.1002/mgg3.70051.
PMID: 39763182 - 10
Is gestational trophoblastic neoplasia more common among women with recurrent hydatidiform moles and biallelic NLRP7 mutations? a 17-years prospective study from India.
Bagga R, Katoch T, Srinivasan R, et al.
European journal of obstetrics, gynecology, and reproductive biology 2025; (311()):114022 doi:10.1016/j.ejogrb.2025.114022.
PMID: 40319759 - 11
Biallelic variant in cyclin B3 is associated with failure of maternal meiosis II and recurrent digynic triploidy.
Fatemi N, Salehi N, Pignata L, et al.
Journal of medical genetics 2021; (58(11)):783-788 doi:10.1136/jmedgenet-2020-106909.
PMID: 32938693
This page explains recurrence risk after triploidy or a partial molar pregnancy for informational purposes only and does not replace medical advice. Discuss your pathology results, hCG monitoring, and plans for another pregnancy with your obstetric or genetics team.
Get notified when new evidence is published on Triploidy syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.